TSXV:NLH - Post Discussion
Post by
BetulaKapital on Apr 28, 2022 9:37am
Convincing indications for Q1 (should presents next week)
Very convincing words from Amedisys and Encompass Q1 reports from their home care business yesterday. Solid and increased earnings, this despite a weak start in early January due to Omicron. Hospitals and hospices have a harder time tying up labor compared to home care, which I have shown with static before.
Add that Nova Leap Health has 3 major acquisitions from exactly at the end of Q4 that will be included in full in Q1 (will probably be released 5 May on historical dates):
December 6: South Carolina - Annual Revenue (USD) $1,788 million and EBITDA of $96,000 (2021)
December 13: Kentucky and Indiana - Annual Revenue (USD) $4.1 million and EBITDA of $825,000 (2021)
December 17: Texas - Annual Revenue (USD) $3,371 million and EBITDA of $325,000
Also remember that these results come from a full year imprinted with Covid-19.
Be the first to comment on this post